Big Pharma faces uncertainty as the Trump administration pushes MFN drug pricing and 100% tariffs on non-US manufactured ...

Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside. See here for more on LLY stock.

Acquisition adds scale, expands monetization channels, and accelerates Blue Ant Media's growth strategy TORONTO, /CNW/ - Blue Ant Media ...

MariMed Inc. (MRMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Last week, the Daily Mail's City Editor joined leading experts in warning he was worried that a terrible financial crash was ...

In the investment field if you are delivering returns aligned to investors expectation, flows will eventually flow. Baroda ...

Investing’s megafunds have done well by catering to their limited partners. That opens up an opportunity for smaller funds.

In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain ...

"[AI] will change the very nature of some of these jobs. But there are places for humans in the loop, so to speak," said Bill Resh.

AI is an enabler. It can accelerate your momentum, help you test ideas and uncover options you hadn’t considered. But it ...

For investors, this represents more than just another government spending program. TheStreet indicates that analysts project ...

Careful planning around succession, market changes and investment choices can help you feel more confident about the years ...